DocGo Inc’s recent filing unveils that its Director Burdiek Michael J acquired Company’s shares for reported $13300.0 on May 23 ’25. In the deal valued at $1.33 per share,10,000 shares were bought. As a result of this transaction, Burdiek Michael J now holds 641,560 shares worth roughly $0.99 million.
Then, Burdiek Michael J bought 15,000 shares, generating $21,450 in total proceeds. Upon buying the shares at $1.43, the Director now owns 631,560 shares.
Before that, Klasko Stephen K. M.D. bought 15,000 shares. DocGo Inc shares valued at $22,350 were divested by the Director at a price of $1.49 per share. As a result of the transaction, Klasko Stephen K. M.D. now holds 15,000 shares, worth roughly $23100.0.
BTIG Research downgraded its DocGo Inc [DCGO] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who decreased its forecast for the stock in late February from “a Buy” to “a Hold”. BTIG Research began covering DCGO with “Buy” recommendation on August 18, 2023. Cantor Fitzgerald started covering the stock on April 21, 2023. It rated DCGO as “an Overweight”.
Price Performance Review of DCGO
On Monday, DocGo Inc [NASDAQ:DCGO] saw its stock jump 6.21% to $1.54. Over the last five days, the stock has lost -3.75%. DocGo Inc shares have fallen nearly -63.68% since the year began. Nevertheless, the stocks have fallen -51.11% over the past one year. While a 52-week high of $5.68 was reached on 02/18/25, a 52-week low of $1.23 was recorded on 05/22/25.
Levels Of Support And Resistance For DCGO Stock
The 24-hour chart illustrates a support level at 1.4700, which if violated will result in even more drops to 1.4000. On the upside, there is a resistance level at 1.5900. A further resistance level may holdings at 1.6400.
The most recent change occurred on April 19, 2022 when Deutsche Bank began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
